Engenharia

Review

Clinical management of Staphylococcus aureus bacteraemia
Guy E Thwaites, Jonathan D Edgeworth, Effrossyni Gkrania-Klotsas, Andrew Kirby, Robert Tilley, M Estée Török, Sarah Walker, Heiman F L Wertheim, Peter Wilson, Martin J Llewelyn, for the UK Clinical Infection Research Group*
Lancet Infect Dis 2011; 11: 208–22 *Members listed at end of paper Centre for Molecular Microbiology and Infection, Imperial College, London, UK (G E Thwaites PhD); Directorate of Infection, Guy’s and St Thomas’s NHS Foundation Trust, London, and Department of Infectious Diseases, King’s College London School of Medicine at Guy’s, King’s College, and St Thomas’ Hospitals, London, UK (J D Edgeworth PhD); Department of Infectious Diseases, Addenbrooke’s Hospital, Cambridge, UK (E Gkrania-Klotsas FRCP, M E Török FRCP); Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK (E Gkrania-Klotsas); Institute of Infection and Global Health, University of Liverpool, Liverpool, UK (A Kirby MBChB); Department of Microbiology, Royal Devon and Exeter Hospital, Exeter, UK (R Tilley MBChB); Medical Research Unit Clinical Trials Unit, London, and National Institute for Healthcare Research Oxford Biomedical Research Centre, Oxford, UK (S Walker PhD); Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Program, Vietnam, and Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK (H F L Wertheim PhD); Department of Microbiology, University College London Hospital, London, UK (P Wilson FRCPath); and Department of Infectious Diseases and Microbioloy, Brighton and Sussex Medical School, Brighton, UK (M J Llewelyn PhD) Correspondence to: Dr Guy Thwaites, Centre for Molecular Microbiology and Infection, Imperial College, South Kensington Campus, Exhibition Road, London SW7 2AZ, UK [e-mail]

Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections worldwide.